News
On track for first patient dosing of SER-252 in Phase 1b clinical trial in advanced Parkinson's disease in Q4 2025 Strengthened balance sheet with recent financing Advancing innovative POZ Platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback